A detailed history of Neos Investment Management LLC transactions in Genmab A/S stock. As of the latest transaction made, Neos Investment Management LLC holds 41,150 shares of GMAB stock, worth $842,340. This represents 0.03% of its overall portfolio holdings.

Number of Shares
41,150
Previous 38,554 6.73%
Holding current value
$842,340
Previous $969 Million 3.55%
% of portfolio
0.03%
Previous 0.04%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$23.84 - $28.48 $61,888 - $73,934
2,596 Added 6.73%
41,150 $1 Billion
Q2 2024

Aug 14, 2024

BUY
$25.13 - $30.27 $659,561 - $794,466
26,246 Added 213.24%
38,554 $969 Million
Q1 2024

May 13, 2024

BUY
$26.43 - $32.77 $9,567 - $11,862
362 Added 3.03%
12,308 $368 Million
Q4 2023

Feb 13, 2024

BUY
$27.94 - $35.44 $333,771 - $423,366
11,946 New
11,946 $380 Million

Others Institutions Holding GMAB

About GENMAB A/S


  • Ticker GMAB
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 658,292,992
  • Market Cap $13.5B
  • Description
  • Genmab A/S develops antibody therapeutics for the treatment of cancer and other diseases primarily in Denmark. The company markets DARZALEX, a human monoclonal antibody for the treatment of patients with multiple myeloma (MM); teprotumumab for the treatment of thyroid eye disease; ofatumurnab, a human monoclonal antibody to treat chronic lymphoc...
More about GMAB
Track This Portfolio

Track Neos Investment Management LLC Portfolio

Follow Neos Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Neos Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Neos Investment Management LLC with notifications on news.